This observation suggests that TPM3P9 potentially impedes the interaction between RBM4 and TCF7L2 pre-mRNA, thereby facilitating the retention in exon 13 of TCF7L2 to promote renal cancer progression. Here, TPM3P9 is linked to renal carcinoma.